Oxytocin acetate, leuprorelin acetate, liraglutide, terlipressin, carbetocin acetate, exenatide acet

Zhejiang Pai peptide biological Co., Ltd. (ZPC), established in July 2015, has obtained the pharmaceutical production license and won the title of "national high tech enterprise". ZPC is located in Shaoxing high tech Industrial Park, with a registered capital of 20 million yuan. The first phase of the company covers an area of 13 mu, with an area of more than 10000 square meters of cGMP / FDA standard plant. It has an annual production capacity of 200kg peptide API, which can meet the large-scale production of pharmaceutical peptides. According to the production demand, the second phase of the plant can be expanded to nearly 80 mu. The company has more than 200 employees, including more than 60 R & D personnel. At present, it has obtained a number of invention patents, and its products are sold at home and abroad. Hangzhou Pai peptide Biochemical Technology Co., Ltd. (HPC), established in May 2014, is wholly owned by Zhejiang Pai peptide biological Co., Ltd.